Related content

Toxicity and Quality of Life after Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy

By Tuttle Todd   Zhang Yan   Greeno Edward   Knutsen Amy  

Annals of Surgical Oncology, Vol. 13, Iss. 12, 2006-12 ,pp. : 1627-1632

Springer Publishing Company

Access to resources Recommend Favorite

Quality of Life After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: An Asian Perspective

By Tan Winson   Wong Joelle   Chia Claramae   Tan Grace   Soo Khee   Teo Melissa  

Annals of Surgical Oncology, Vol. 20, Iss. 13, 2013-12 ,pp. : 4219-4223

Springer Publishing Company

Access to resources Recommend Favorite

Cytoreductive Surgery and Intraoperative Hyperthermic Intraperitoneal Chemotherapy with Paclitaxel: A Clinical and Pharmacokinetic Study

By Bree Eelco   Rosing Hilde   Filis Dimitris   Romanos John   Melisssourgaki Maria   Daskalakis Markos   Pilatou Maria   Sanidas Elias   Taflampas Panagiotis   Kalbakis Konstantinos   Beijnen Jos   Tsiftsis Dimitris  

Annals of Surgical Oncology, Vol. 15, Iss. 4, 2008-04 ,pp. : 1183-1192

Springer Publishing Company

Access to resources Recommend Favorite

Costs and clinical outcome of neoadjuvant systemic chemotherapy followed by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal carcinomatosis from gastric cancer

By Hultman Bo   Lundkvist Jonas   Glimelius Bengt   Nygren Peter   Mahteme Haile  

Acta Oncologica, Vol. 51, Iss. 1, 2012-01 ,pp. : 112-121

Informa Healthcare

Access to resources Recommend Favorite

Cytoreductive Surgery with Intraperitoneal Hyperthermic Chemotherapy for Malignant Peritoneal Mesothelioma: Mitomycin Versus Cisplatin

By Blackham Aaron  

Annals of Surgical Oncology, Vol. 17, Iss. 10, 2010-10 ,pp. : 2720-2727

Springer Publishing Company

Access to resources Recommend Favorite